A new pill to treat HIV just got approved — and it could shake up a $22 billion market (GILD)
|02/07/2018||Posted by BusinessMediaguide.Com under General World News||
- The FDA just approved a new combination of drugs to treat HIV.
- The treatment combines three drugs into one daily pill: bictegravir, emtricitabine and tenofovir alafenamide.
- The new approval could shake up the $22 billion HIV drug market.
The FDA just approved a new, once-a-day pill to treat HIV.
The pill, made by Gilead Sciences, contains bictegravir, along with emtricitabine and tenofovir alafenamide, two drugs that are considered the “backbone” of HIV treatments. Of the three treatments contained in the pill, bictegravir is the only totally new element.
Up until recently, people living with HIV suppress the virus with a regimen of three read more >>>